Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR+) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC).
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Rachel N. Grisham, Karen Li, Alexia Iasonos, Jeffrey Girshman, Karen Anne Cadoo, Chrisann Kyi, Vicky Makker, Seth M. Cohen, Roisin Eilish O'Cearbhaill, Paul Sabbatini, Alison M. Schram, Tiffany A. Troso-Sandoval, Viola N. Chitiyo, Maureen Kennedy, Elena N. Ngangom, Dasom N. Jang, William P. Tew, Sarah Chiang, Carol Aghajanian
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3030914903
